Metro I.V. In Plastic Container

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

58 API Suppliers, 16 USDMF, 13 CEP/COS, 1 JDMF, 3 EU WC, 15 KDMF, 11 NDC API, 18 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

FINISHED DOSAGE FORMULATIONS

409 FDF Dossiers, 118 FDA Orange Book, 87 Europe, 18 Canada, 14 Australia, 50 South Africa, 122 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 500MG/100ML, INJECTABLE;INJECTION - 500MG/100ML, GEL;TOPICAL - 0.75%, GEL;VAGINAL - 0.75%, GEL;VAGINAL - 1.3%, CREAM;TOPICAL - 0.75%, SUSPENSION;ORAL - 500MG/5ML, GEL;TOPICAL - 1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 6 SPI Pharma, 13 DKSH, 4 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 29 BASF, 1 Clariant, 17 Corel Pharma Chem, 6 DFE Pharma, 3 Finar, 11 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Lubrizol Life Science Health, 15 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 32 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 45 Thickeners and Stabilizers, 39 Solubilizers, 34 Topical, 34 Controlled & Modified Release, 32 Direct Compression, 31 Disintegrants & Superdisintegrants, 27 Granulation, 23 Film Formers & Plasticizers, 20 Parenteral, 19 Lubricants & Glidants, 17 Taste Masking, 14 Co-Processed Excipients, 11 Chewable & Orodispersible Aids, 9 Empty Capsules, 8 Emulsifying Agents, 7 Rheology Modifiers, 6 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 58 News #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 83 Regulatory FDF Prices

MARKET PLACE

75 APIs, 40 FDF Dossiers

PATENTS & EXCLUSIVITIES

11 US Patents, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 10 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 19737 / DOSAGE - GEL;TOPICAL - 0.75%

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
METRONIDAZOLE(UNII: 140QMO216E) (Metronidazole - UNII:140QMO216E)	METRONIDAZOLE	7.5mg in 1

Inactive Ingredients

Ingredient Name	Owen Laboratories	Medimetriks Pharmaceuticals, Inc.
CARBOMER 940(4Q93RCW27E)
edetate disodium(7FLD91C86K)
methylparaben(A2I8C7HI9T)
PROPYLENE GLYCOL(6DC9Q167V3)
propylparaben(Z8IX2SC1OH)
sodium hydroxide(55X04QC32I)
WATER(059QF0KO0R)

Drug Product Composition: Metro I.V. In Plastic Container